NL-OMON39868已完成3 期
ROX CONTROL HTN Study: A Prospective, Randomized, Open-Label, Multicenter Study to Evaluate the ROX Coupler in Patients with Resistant Hypertension - ROX CONTROL HT
Clinical Department0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Office Systolic blood pressure >= 140 mmHg based on an average of 3 blood pressure readings;2. Ambulatory Blood Pressure Monitoring (ABPM) daytime average:
- •Systolic blood pressure (SBP) >= 135 mmHg;
- •Diastolic blood pressure (DBP) >= 85 mmHg ;See Protocol Section 4.4.1 for complete Inclusion Criteria
排除标准
- •1. Secondary hypertension attributable to a cause other than sleep apnea
- •2. Type I diabetes
- •See Protocol Section 4.4.2 for complete Exclusion Criteria
研究者
相似试验
已完成
3 期
A Multicenter Study to Evaluate the ROX Arteriovenous Coupler in Patients With Treatment-Resistant HypertensionHypertensionNCT01642498ROX Medical, Inc.100
尚未招募
不适用
Prospective randomized controlled study of CRRT hemofilters for the treatment of acute kidney injury (AKI)Acute kidney injury (AKI)JPRN-UMIN000016105Wakayama Medical University60
已完成
2 期
The randomized controlled trial of the R-THP-COP therapy (14 days) versus R-CHOP therapy (14 days) for treatment of patients under the age of 70 with untreated advanced stage diffuse large B-cell lymphoma, Phase II and III studydiffuse large B-cell lymphomaJPRN-UMIN000007283Gifu University Hospital80
已完成
2 期
The randomized controlled trial of the R-THP-COP therapy versus R-CHOP therapy for treatment of elderly patients with untreated advanced stage diffuse large B-cell lymphoma, Phase II and III studydiffuse large B-cell lymphomaJPRN-UMIN000007282Gifu University Hospital70
已完成
3 期
Registry to Evaluate the ROX COUPLER in Patients With Resistant or Uncontrolled HypertensionBlood Pressure, HighBlood Pressure, ResistantBlood Pressure, UncontrolledHypertensionNCT01885390ROX Medical, Inc.83